Gastric cancer (advanced HER-2 positive) - trastuzumab (herceptin): addendum to the Evidence Review group report

Gastric cancer (advanced HER-2 positive) - trastuzumab (herceptin): addendum to the Evidence Review group report

Gastric cancer (advanced HER-2 positive) - trastuzumab (herceptin): addendum to the Evidence Review group report
06 July 2010
(13.38 Kb 3 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 06 July 2010